Greenfern Industries Ltd
NZX:GFI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
NZ |
|
Infotel SA
PAR:INF
|
FR |
|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
UK |
|
D
|
Dalata Hotel Group PLC
F:DHG
|
IE |
|
M
|
Maxar Technologies Inc
TSX:MAXR
|
US |
|
Catella AB
F:SKVB
|
SE |
|
J
|
Jiangnan Mould & Plastic Technology Co Ltd
SZSE:000700
|
CN |
|
Lojas Quero-Quero SA
BOVESPA:LJQQ3
|
BR |
|
T
|
Thrace Plastics Holding and Commercial SA
ATHEX:PLAT
|
GR |
|
C
|
Company K Partners Ltd
KOSDAQ:307930
|
KR |
|
C
|
Cheetah Holdings Bhd
KLSE:CHEETAH
|
MY |
|
LG Balakrishnan & Bros Ltd
NSE:LGBBROSLTD
|
IN |
|
Arovella Therapeutics Ltd
ASX:ALA
|
AU |
|
Chemours Co
NYSE:CC
|
US |
|
Sharda Cropchem Ltd
NSE:SHARDACROP
|
IN |
|
F
|
Fastenal Co
F:FAS
|
US |
|
Lammhults Design Group AB
STO:LAMM B
|
SE |
|
Baazeem Trading Company CJSC
SAU:4051
|
SA |
|
Enervit SpA
MIL:ENV
|
IT |
|
New Talisman Gold Mines Ltd
NZX:NTL
|
NZ |
|
STO Express Co Ltd
SZSE:002468
|
CN |
|
Supreme Engineering Ltd
NSE:SUPREMEENG
|
IN |
|
D
|
Dadelo SA
WSE:DAD
|
PL |
|
S
|
South Malaysia Industries Bhd
KLSE:SMI
|
MY |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of GFI.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
GFI Competitors Multiples
Greenfern Industries Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NZ |
G
|
Greenfern Industries Ltd
NZX:GFI
|
2.7m NZD | 6 | -1.7 | -2.4 | -2.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.5 | 16.9 | 7.1 | 8.8 |